Physician profile
Dynella Russo
NPI 1720496532
$1,205.75
in general payments reported to CMS, 2019-2025
15 companies · $849 in 2025
The $849 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $35.96 · 2024: $321 · 2025: $849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,205.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $277.87 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Mentor Worldwide LLC | $221.70 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Axogen | $152.79 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $132.09 | 2024-2025 | Exparel |
| Davol INC. | $85.31 | 2024 | Arista Ah Flexitip |
| Acera Surgical, INC. | $52.34 | 2024-2025 | Restrata Wound Matrix |
| Avita Medical Americas, LLC | $50.06 | 2025 | Recell, Permeaderm, Cohealyx |
| Kerecis Limited | $49.86 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Depuy Synthes Sales INC. | $43.81 | 2025 | Matrixmandible |
| Solventum Corporation | $33.77 | 2024-2025 | V.A.C.Ulta, Prevena, V.A.C. Veraflo Cleanse Choice |
| Baxter Healthcare | $31.89 | 2023-2024 | Tisseel |
| Stryker Corporation | $22.04 | 2024 | Na |
| Kci USA, INC. | $19.21 | 2023 | Promogran Prisma, Activ.A.C. |
| Smith+Nephew, INC. | $18.03 | 2025 | Collagenase Santyl |
| Abbvie INC. | $14.98 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dynella Russo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.